Have a personal or library account? Click to login
The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography Cover

The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography

Open Access
|Aug 2018

References

  1. 1. POCHA C, KOLLY P, DUFOUR JF. Nonalcoholic fatty liver disease-related hepatocellular carcinoma: A problem of growing magnitude. Semin Liver Dis. 2015; 35(3):304-17.10.1055/s-0035-156294926378646
  2. 2. FRIEDRICH-RUST M, SCHOELZEL F, MAIER S, SEEGER F, REY J, FICHTLSCHERER S, et al. Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: A single-blinded prospective mono-center study. PLoS One. 2017; 12(10):e0186720.10.1371/journal.pone.0186720565807629073252
  3. 3. PERERA N, INDRAKUMAR J, ABEYSINGHE WV, FERNANDO V, SAMARAWEERA WM, LAWRENCE JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: An observational study from Sri Lanka. BMC Cardiovasc Disord. 2016;16:37.10.1186/s12872-016-0212-8475170126869052
  4. 4. GAUDIO E, NOBILI V, FRANCHITTO A, ONORI P, CARPINO G. Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med. 2012; 7 Suppl 3:S297-305.10.1007/s11739-012-0826-523073871
  5. 5. BONCI E, CHIESA C, VERSACCI P, ANANIA C, SILVESTRI L, PACIFICO L. Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: A systematic review and meta-analysis. Biomed Res Int. 2015; 2015:213737.10.1155/2015/213737452989926273598
  6. 6. PARK HE, KWAK MS, KIM D, KIM MK, CHA MJ, CHOI SY. Nonalcoholic fatty liver disease is associated with coronary artery calcification development: A longitudinal study. J Clin Endocrinol Metab. 2016; 101(8):3134-43.10.1210/jc.2016-152527253666
  7. 7. LI XL, SUI JQ, LU LL, ZHANG NN, XU X, DONG QY, et al. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: A concise review. Lipids Health Dis. 2016; 15:53.10.1186/s12944-016-0221-8478561626965314
  8. 8. NSEIR W, SHALATA A, MARMOR A, ASSY N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011; 56(12):3439-49.10.1007/s10620-011-1767-y21655948
  9. 9. ADAMS LA, ANSTEE QM, TILG H, TARGHER G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017; 66(6):1138-53.10.1136/gutjnl-2017-31388428314735
  10. 10. WANG P-W, HSIEH C-J, PSANG L-C, CHENG Y-F, LIOU C-W, WENG S-W, et al. Fatty liver and chronic inflammation in Chinese adults. Diabetes Research and Clinical Practice. 2008; 81(2):202-08.10.1016/j.diabres.2008.04.01418534708
  11. 11. PASARIN M, ABRALDES JG, LIGUORI E, KOK B, LA MURA V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol. 2017; 23(37):6777-87.10.3748/wjg.v23.i37.6777564561229085222
  12. 12. KLISIC A, ISAKOVIC A, KOCIC G, KAVARIC N, JOVANOVIC M, ZVRKO E, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2017.10.1055/s-0043-11866728895641
  13. 13. KIM J, LEE DY, PARK SE, PARK CY, LEE WY, OH KW, et al. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS One. 2017; 12(7):e0180118.10.1371/journal.pone.0180118550145928686633
  14. 14. KOROGLU E, CANBAKAN B, ATAY K, HATEMI I, TUNCER M, DOBRUCALI A, et al. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. Turk J Gastroenterol. 2016; 27(4):361-6.10.5152/tjg.2016.1610627458852
  15. 15. EMRE A, TERZI S, CELIKER E, SAHIN S, YAZICI S, ERDEM A, et al. Impact of nonalcoholic fatty liver disease on myocardial perfusion in nondiabetic patients undergoing primary percutaneous coronary intervention for ST - segment elevation myocardial infarction. The American Journal of Cardiology. 2015; 116(12):1810-4.10.1016/j.amjcard.2015.09.02126506122
  16. 16. WANG Y, LI YY, NIE YQ, ZHOU YJ, CAO CY, XU L. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine. 2013; 6(1):77-84.10.3892/etm.2013.1090373556823935723
  17. 17. NADERIAN M, KOLAHDOOZAN S, SHARIFI AS, GARMAROUDI G, YASERI M, POUSTCHI H, et al. Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; Prevalence and its association with metabolic disorders: A cross-sectional study. Archives of Iranian Medicine. 2017; 20(4):211-17.
  18. 18. WU R, HOU F, WANG X, ZHOU Y, SUN K, WANG Y, et al. Nonalcoholic fatty liver disease and coronary artery calcification in a northern Chinese population: A cross sectional study. Sci Rep. 2017; 7(1):9933.10.1038/s41598-017-09851-5557729228855585
  19. 19. BAHARVAND-AHMADI B, SHARIFI K, NAMDARI M. Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. ARYA Atheroscler. 2016; 12(4):201-05.
  20. 20. SUN L, LU SZ. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J (Engl). 2011; 124(6):867-72.
  21. 21. CHOI DH, LEE SJ, KANG CD, PARK MO, CHOI DW, KIM TS, et al. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013; 19(38):6453-7.10.3748/wjg.v19.i38.6453380131624151364
  22. 22. ARSLAN U, TURKOGLU S, BALCIOGLU S, TAVIL Y, KARAKAN T, CENGEL A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007; 18(6):433-6.10.1097/MCA.0b013e3282583c0d17700213
DOI: https://doi.org/10.2478/rjim-2018-0009 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 167 - 172
Submitted on: Jan 13, 2018
Published on: Aug 29, 2018
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2018 Taraneh Faghihi Langroudi, Habib Haybar, Saeed Alipour Parsa, Mohamad Mahjoorian, Isa Khaheshi, Mohammadreza Naderian, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.